AmCare Genomics is Laboratory Services (Healthcare) in China that focus on oncology diagnosis business. Founded in 2015. They cover business area such as provider, clinical genetic, clinical oncology diagnosis, comprehensive diagnostic service, clinical biochemical genetic, clinical molecular genetic, client, medical diagnostic accuracy, well treatment decision.
Laboratory Services (Healthcare)
2015
( 9 years old in 2024 )
Oncology Diagnosis
-
Unit 201, Block 4-C, Phase 2
No. 9, Luoxuan 4th Road, International Biological Island
Guangzhou, Guangdong 510300
China
Private
providerclinical geneticclinical oncology diagnosiscomprehensive diagnostic serviceclinical biochemical geneticclinical molecular geneticclientmedical diagnostic accuracywell treatment decision
* We use standard office opening hours in near AmCare Genomics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AmCare Genomics is Laboratory Services (Healthcare) business from China that founded in 2015 (9 years old in 2024), AmCare Genomics business is focusing on Oncology Diagnosis.
AmCare Genomics headquarter office and corporate office address is located in Unit 201, Block 4-C, Phase 2 No. 9, Luoxuan 4th Road, International Biological Island Guangzhou, Guangdong 510300 China.
AmCare Genomics was founded in China.
In 2024, AmCare Genomics is currently focus on oncology diagnosis sector.
Above is snippet of Google Trends for "oncology diagnosis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AmCare Genomics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
